1. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer. Issue 3 (December 2015) Authors: Schmid-Bindert, Gerald; Engel-Riedel, Walburga; Reck, Martin; Schuette, Wolfgang; Stöhlmacher, Jan; Fischer, Jürgen R.; Mazières, Julien; Chouaid, Christos; Wolf, Martin; Vinolas, Nuria; Soldatenkova, Victoria; Ripoche, Veronique; Nguyen, Tuan; Visseren-Grul, Carla Journal: Lung cancer Issue: Volume 90:Issue 3(2015:Dec.) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study. (February 2016) Authors: Smit, Egbert; Moro-Sibilot, Denis; Carpeño, Javier de Castro; Lesniewski-Kmak, Krzysztof; Aerts, Joachim; Villatoro, Rosa; Kraaij, Kees; Nacerddine, Karim; Dyachkova, Yulia; Smith, Karen T.; Girvan, Allicia; Visseren-Grul, Carla; Schnabel, Philipp A. Journal: Lung cancer Issue: Volume 92(2016) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC). Issue 2 (May 2015) Authors: Garrido, Pilar; Engel-Riedel, Walburga; Serke, Monika; Giraud, Philippe; Ricardi, Umberto; Vallejo, Carmen; Visseren-Grul, Carla; Ameryckx, Sophie; Soldatenkova, Victoria; Chouaki, Nadia; Novello, Silvia Journal: Lung cancer Issue: Volume 88:Issue 2(2015:May) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study. Issue 3 (December 2015) Authors: Moro-Sibilot, Denis; Smit, Egbert; de Castro Carpeño, Javier; Lesniewski-Kmak, Krzysztof; Aerts, Joachim G.; Villatoro, Rosa; Kraaij, Kees; Nacerddine, Karim; Dyachkova, Yulia; Smith, Karen T.; Girvan, Allicia; Visseren-Grul, Carla; Schnabel, Philipp A. Journal: Lung cancer Issue: Volume 90:Issue 3(2015:Dec.) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. Issue 2 (May 2015) Authors: Moro-Sibilot, Denis; Smit, Egbert; de Castro Carpeño, Javier; Lesniewski-Kmak, Krzysztof; Aerts, Joachim; Villatoro, Rosa; Kraaij, Kees; Nacerddine, Karim; Dyachkova, Yulia; Smith, Karen T.; Taipale, Kaisa; Girvan, Allicia C.; Visseren-Grul, Carla; Schnabel, Philipp A. Journal: Lung cancer Issue: Volume 88:Issue 2(2015:May) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer. (2nd October 2020) Authors: Yoh, Kiyotaka; Atagi, Shinji; Reck, Martin; Garon, Edward B.; Ponce Aix, Santiago; Moro-Sibilot, Denis; Winfree, Katherine B.; Frimodt-Moller, Bente; Zimmermann, Annamaria; Visseren-Grul, Carla; Nakagawa, Kazuhiko Journal: Current medical research and opinion Issue: Volume 36:Number 10(2020) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019) Authors: Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2019) Authors: Nakagawa, Kazuhiko; Garon, Edward B; Seto, Takashi; Nishio, Makoto; Ponce Aix, Santiago; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Enatsu, Sotaro; Zimmermann, Annamaria; Frimod... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗